Aktie A3C69Y INTELLIGENT MEDICINE ACQUISITION CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen Intelligent Medicine Acquisition Corp. Nasdaq

Aktien

A3C69Y

US45828D2053

IQMDU

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
INTELLIGENT MEDICINE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
Intelligent Medicine Acquisition Corp.(NasdaqGM:IQMD) dropped from NASDAQ Composite Index
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Intelligent Medicine Acquisition Corp. Auditor Raises 'Going Concern' Doubt
INTELLIGENT MEDICINE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
INTELLIGENT MEDICINE ACQUISITION CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Intelligent Medicine Acquisition Corp. Announces Adjournment of Special Meeting of Stockholders
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Intelligent Medicine Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022
Certain Class B Common Stock of Intelligent Medicine Acquisition Corp. are subject to a Lock-Up Agreement Ending on 3-MAY-2022.
INTELLIGENT MEDICINE ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DFJK Aktie
  4. A3C69Y Aktie
  5. Nachrichten Intelligent Medicine Acquisition Corp.
  6. Andere Sprachen